Company / strategic investorRegistered location :New York, NY

Armistice Capital Master Fund LtdDeclared Swiss shareholdings

Armistice Capital Master Fund Ltd: 1 Swiss companies with a declared holding, including Addex Therapeutics Ltd. Latest filing: 23.12.2025.

Disclosure tracking · company alerts with Pro

Estimated value (CHF): …
Swiss companies held: 1
Largest position: 31,31 %; Addex Therapeutics Ltd
12-month trend: Not determinable; 0 rate rises · 0 rate falls
Latest filing: 23.12.2025; Active since 2020

Declared Swiss portfolio

Latest declared rate per company

Sector allocation

Share of companies held

Addex Therapeutics Ltd

31,31 %18.01.2024

How to read these figures?

Rates come from the 43 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure1 controlled by

Controlled by

Group entities that file jointly with this shareholder as its head.

Armistice Capital LLC3 · 31.12.2013

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

visible history: 37

90 days · Downward crossings

visible history: 0

First disclosure: 12.09.2020Last disclosure: 23.12.2025

Nature of disclosed positions

Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.

Equity holdings

Rights / derivatives

Latest shareholding disclosures

Below thresholdShareholdings

MindMaze Therapeutics Holding SA

Armistice Capital Master Fund Ltd · Single shareholder

Declared Swiss portfolio

Sector allocation

Group structure

Controlled by

Disclosure behaviour

Nature of disclosed positions

Latest shareholding disclosures

Follow Armistice Capital Master Fund Ltd’s disclosures

Management purchases in this portfolio

Common questions

Explore further

Recent insider purchases

Insider barometer